Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination - Related Studies

Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

This study has been completed.

Study NCT00044668. Last updated on November 5, 2007. Information provided by Amylin Pharmaceuticals, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetes Mellitus, Type 2

2	Additional conditions recognized in this trial
		Diabetes Mellitus

3	More general conditions related to this trial
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Metabolic Diseases

4	Interventions listed in this trial
		AC2993 (synthetic exendin-4)

5	Additional drug interventions recognized in this trial
		Exenatide
		Metformin

6	More general drug interventions related to this trial
		Hypoglycemic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Amylin Pharmaceuticals, Inc.
		Eli Lilly and Company